RETN and colorectal carcinoma: The summary WMD of resistin levels between CRC patients and control group was 1.47 ng/mL (95% CI: 0.78 to 2.16), and z-score for overall effect was 4.19 (p < 0.0001), which revealed a possibility that higher circulating resistin level was associated with higher risk of colorectal tumor.